Inventor · disambiguated record
Jin Tian
Also filed as: TIAN JIN
0 granted patents·12 pending applications·0 citations·filing 2004–2022
Top patents by PatentIndex Score
12 records- 0156US2025002491A1N,n-dimethyl-4-(7-(n-(1-methylcyclopropyl)sulfamoyl)-imidazo[1,5-a]pyridin-5-yl)piperazine-1-carboxamide derivatives and the corresponding pyrazolo[1,5-a]pyridine derivatives as parg inhibitors for the treatment of cancerFORX THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0256US2024425498A1Parg inhibitory compoundsFORX THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0355US2024270731A1Deuterated compoundsALEBUND PHARMACEUTICALS HONG KONG LTD·Filed 2022·Application pending·0 cites
- 0450US2005074488A1Use of vitamin Ds to down regulate the renin-angiotensin-aldosterone systemFiled 2004·Application pending·0 cites
- 0547US2005192255A1Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular diseaseFiled 2004·Application pending·0 cites
- 0646US2005148557A1Use of Vitamin Ds to treat kidney diseaseFiled 2004·Application pending·0 cites
- 0745US2005192256A1Methods of using vitamin D compounds in the treatment of patients undergoing hemodialysisFiled 2004·Application pending·0 cites
- 0843US2005209203A1Use of vitamin Ds or vitamin D analogs to treat cardiovascular diseaseTIAN JIN·Filed 2004·Application pending·0 cites
- 0942US2007093459A1Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular diseaseTIAN JIN·Filed 2006·Application pending·0 cites
- 1040US2006171983A1Use of Vitamin D receptor activators or Vitamin D analogs to treat cardiovascular diseaseTIAN JIN·Filed 2005·Application pending·0 cites
- 1138US2019151290A1Aleglitazar for the treatment of diabetic kidney diseaseHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 1237US2005124591A1Use of vitamin Ds to treat kidney diseaseFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jin Tian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →